2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 15- Coagulation and Thrombosis I (Xeno Track)

32.395 - Where do platelets go after pig-to-baboon liver xenotransplantation? Evidence for platelet-WBC aggregation

Presenter: Burcin, Ekser, Pittsburgh, United States
Authors: Burcin EKSER1,2, Chih Che Lin1, Cassandra Long1, Gabriel J. Echeverri1,5, Hidetaka Hara1, Donna B. Stolz3, David Ayares4, David K.C. Cooper1, Bruno Gridelli1,5, Mohamed Ezzelarab1

395

Where do platelets go after pig-to-baboon liver xenotransplantation? Evidence for platelet-WBC aggregation

Burcin EKSER1,2, Chih Che Lin1, Cassandra Long1, Gabriel J. Echeverri1,5, Hidetaka Hara1, Donna B. Stolz3, David Ayares4, David K.C. Cooper1, Bruno Gridelli1,5, Mohamed Ezzelarab1

1Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, United States; 2Department of Surgery, Transplantation and Advanced Technologies, Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy; 3Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, PA, United States; 4Revivicor, Inc., Blacksburg, VA, United States; 5Mediterranean Institute for Transplantation and Advanced Specialized Therapies, ISMETT, Palermo, Italy

Background: Severe thrombocytopenia occurs after pig-to-baboon orthotopic liver transplantation (LTx), and limits survival to <8 days. The underlying mechanisms causing thrombocytopenia are not fully understood.

Methods: LTx using genetically-engineered pigs (GTKO, n=2; GTKO/CD46, n=8) was carried out with clinically acceptable immunosuppression in baboons. Platelet count, mean platelet volume (MPV), lymphocyte, monocyte, and neutrophil absolute numbers were monitored. In two recipients, platelet-WBC aggregation (CD42+ or CD62+ aggregates) was monitored daily by flow cytometry. Platelet deposition in the liver grafts was assessed by immunohistochemistry and electron microscopy.

Results: Profound thrombocytopenia occurred in all baboons (n=10) within 4h. Mean platelet count (x103/mm3) fell to 63 within 4h, and to 6 by day 3, despite fresh blood or human platelet transfusions. MPV remained normal. Flow cytometry demonstrated platelet and platelet-WBC aggregates in the blood beginning within 4h. Before LTx, lymphocyte, monocyte and neutrophil aggregates with platelets were 1-3%. After LTx, lymphocyte/platelet, monocyte/platelet, and neutrophil/platelet aggregates increased respectively to 24, 8, 6% at 4h, 18, 13, 3% on day 1, and 54, 67, 14% on day 5. Despite immediate thrombocytopenia, bleeding (decrease in Hct and Hb, melena stools, purpura) did not develop before days 2-3. Liver biopsies taken at 2h and at euthanasia showed platelet aggregates within the sinusoids. At euthanasia, platelet aggregates were also present in the native lungs. Despite profound thrombocytopenia, rejection of the liver grafts was not observed.

Conclusions: (1) Platelet activation (increased WBC-platelet aggregation) occurred within 4h after LTx. (2) The platelet count alone may give a misleading impression of the total number of platelets in the circulation, but (3) their presence does not imply adequate function. (4) Clodronate liposomes failed to reduce the early loss of platelets, suggesting that Kupffer cells did not remove them from the circulation. (5) Platelets and platelet-WBCs aggregate in the liver sinusoids and in native lungs, but we cannot exclude phagocytosis by liver endothelial cells.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada